Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 浙江华康药业股份有限公司创始于1962年,是一家从事多种功能性糖醇及健康食品配料研发、生产、销售的国家高新技术企业。 公司秉持质量、职业健康安全、绿色低碳循环发展理念,通过GMP、ISO9001、ISO14001、ISO45001、ISO50001、FSSC22000等多项管理体系认证,以及Intertek绿叶标志认证,被评为“国家绿色工厂”、“节能环保领军企业”、“中国轻工业发酵行业十强企业”。 公司获得国家企业技术中心认定,主导和参与木糖醇、山梨糖醇、麦芽糖醇等四十余项国家标准、行业标准及团体标准的制定。同时,公司与国内外众多院校合作,开展核心技术的研究和攻关,创新推进科技成果转化,荣获中国专利优秀奖、中国轻工业联合会科学技术进步奖一等奖等奖励,木糖醇产品被工信部评为“单项冠军产品”。 未来,华康股份将继续以“做世界领先的糖醇专家”为愿景,致力于功能性糖醇和健康食品配料的研究开发和技术创新,携手国内外更多的合作伙伴,共创甜美事业,共享健康生活。 | ||||||||||||||||||||||||
Main Business | “木糖醇、山梨糖醇、麦芽糖醇、果葡糖浆等多种功能性糖醇、淀粉糖产品的研发、生产、销售” | ||||||||||||||||||||||||
Legal Representative | 陈德水 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 吴志平 | ||||||||||||||||||||||||
Solicitors | 国浩律师(杭州)事务所 | ||||||||||||||||||||||||
Auditors | 天健会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0570-6035901 | ||||||||||||||||||||||||
Fax No | 0570-6031552 | ||||||||||||||||||||||||
Website | www.huakangpharma.com/ | ||||||||||||||||||||||||
zqb@huakangpharma.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 09/02/2021 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 1.630 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.700 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 12.332 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 4.402B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |